This model somewhat supports and expands the gene dosage hypothesis through the experimental validation that a dysregulation of polycystin-1 through overexpression of the protein can induce an ADPKD specific phenotype in rodents, in addition to significantly reduced polycystin-1 expression as it has previously been shown. The gene discussed is PKD1; the disease is autosomal dominant polycystic kidney disease.